NuSil Technology LLC, a portfolio company of New Mountain Capital, said Wednesday that it named Ernest Waaser as its CEO. He takes over from NuSil’s co-founder and CEO, Dick Compton, who is retiring as CEO, but will continue to serve as Chairman of the NuSil Board of Directors. Most recently, Waaser was an Operating Partner at Linden Capital Partners. Carpinteria, California-based NuSil supplies medical and space-grade silicones.
Carpinteria, California (PRWEB) March 25, 2015
NuSil Technology LLC (http://www.nusil.com), the global leader in high purity medical and space-grade silicones, announces the appointment of Ernest Waaser as its new Chief Executive Officer. Mr. Waaser brings over 30 years of experience leading numerous public and privately-held healthcare companies. He takes over from NuSil’s co-founder and CEO, Dick Compton, who is retiring as CEO, but will continue to serve as Chairman of the NuSil Board of Directors.
Prior to NuSil, Mr. Waaser was an Operating Partner at Linden Capital Partners and previous to that served as CEO of Systagenix Wound Management, a private equity-backed spinout of Johnson & Johnson’s advanced wound care unit, where he led the business through a period of growth resulting in a sale to Kinetic Concepts, Inc.
Mr. Waaser spent his early career in various roles with DuPont’s chemical, industrial and imaging businesses. In the nearly two decades following his career at DuPont, Mr. Waaser held top leadership positions at a number of healthcare businesses, including President of Teleflex Medical, Chief Executive Officer of Hill-Rom, and Chief Operating Officer of Sterling Diagnostic Imaging, a leveraged buy-out of DuPont’s medical imaging assets. Mr. Waaser previously served on the board of AdvaMed and on the advisory board of Xavier University Department of Health Administration. He holds a Bachelor of Science in Nuclear Engineering from Mississippi State University and a Master of Engineering from the University of South Carolina.
“We are thrilled to have an executive of Ernest’s caliber join the NuSil team,” said Matt Holt, a member of the Board of Directors and Managing Director at New Mountain Capital, NuSil’s majority shareholder. “With his proven track record of growing global Medtech businesses, we believe he is absolutely the right person to lead NuSil through its next phase of growth and expansion. Our ability to recruit this kind of talent speaks to the outstanding job that Dick Compton and the management team have done in building an exciting, growth oriented environment at NuSil. Dick is a true icon in the specialty silicone industry and we are pleased that he will continue as Chairman of the Board.”
“I am delighted to be joining NuSil and I look forward to leading the growth of the outstanding company that Dick and the executive team have built,” said Mr. Waaser. “NuSil clearly differentiates itself with its high-touch, personalized approach to the customer experience. Combining that with its world class technical capabilities makes NuSil the partner of choice for the world’s most demanding silicone applications. I’m thrilled to lead an organization that truly delivers on its brand promise.”
For more information, please contact NuSil at +1 805-684-8780, or visit http://www.nusil.com.
About NuSil Technology LLC
NuSil Technology, the global leader in medical and space-grade silicones, brings more than three decades of success in developing products for the most demanding applications, from deep inside the human body to the harsh conditions of outer space. It operates state-of-the-art laboratories and manufacturing facilities in North America and provides on-site, in-person application engineering support worldwide.